Komori
Treasury Shares5187CREATE MEDIC CO.,LTD.Electrical Equipment and Precision Instruments

Notice Regarding the Status of Share Repurchases and Completion of the Repurchase

The Company purchased 22,100 treasury shares through market purchases for approximately ¥24.93 million between 1 August and 24 August 2026, completing the acquisition of treasury shares based on the resolution of the Board of Directors in March. On a cumulative basis, 430,000 shares were acquired for a total acquisition cost of ¥493,511,600.

Worth reading
62In focus
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Neutral
Direction inferred from the company’s description.
Scale
22100
Shares
Wording
Definitive
How definitive the wording is.

Progress against acquisition limit

Acquisition completedMarket purchases on the Tokyo Stock Exchange

Resolved 27 March 2026 / Acquisition period 30 March 2026 to 31 October 2026

100.0%
Cumulative utilization rate
Limit
Number of Shares430,000 shares (maximum)
94.9%
Cumulative utilization rate
LimitShares 100.0%
Amount¥520,000,000 (maximum)

The darker band is the portion acquired this time (1 August 2026–24 August 2026). 株数の枠が先に埋まり、金額の上限は使い残しています。

Number of Shares
Limit430,000 shares (maximum)
Cumulative total430,000 shares (through 24 August 2026)
Current22,100 shares
Amount
Limit¥520,000,000 (maximum)
Cumulative total¥493,511,600 (through 24 August 2026)
Current¥24,938,400
Average acquisition price for this transaction (calculated)¥1,128 per shareCurrent acquisition price ÷ current number of shares acquired
Whether acquisition has been completed

Acquisition completed on 24 August 2026

消化率と残りは、会社が示した累計・今回と上限から算出しています。進捗率=上限に対してどこまで使ったかの割合です。

Progress against acquisition limit
ItemDetails
Total number of shares acquired in this transaction22,100 shares
Total current acquisition price¥24,938,400
Acquisition date/acquisition period1 August 2026–24 August 2026
Method of acquisitionMarket purchases on the Tokyo Stock Exchange
Cumulative number of shares acquired430,000 shares (through 24 August 2026)
Cumulative acquisition cost¥493,511,600 (through 24 August 2026)
Resolution date27 March 2026
Maximum number of shares to be acquired430,000 shares (maximum)
Total acquisition price¥520,000,000 (maximum)
Acquisition period under the resolution30 March 2026 to 31 October 2026
Whether acquisition has been completedAcquisition completed on 24 August 2026
Items this document does not state (2)
Percentage of total issued sharesAverage Acquisition Price

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

The acquisition of treasury shares was conducted pursuant to the provisions of Article 156 of the Companies Act, as applied mutatis mutandis pursuant to Article 165, paragraph 3 of the same Act. No reason was stated for completing the acquisition.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice Regarding the Status of Share Repurchases and Completion of the Repurchase | CREATE MEDIC CO.,LTD. (5187) timely disclosure | Komori